Shun Lin - ScinoPharm Taiwan Director Devel
| 1789 Stock | TWD 22.20 0.50 2.20% |
Insider
Shun Lin is Director Devel of ScinoPharm Taiwan
| Phone | 886 6 505 2888 |
| Web | https://www.scinopharm.com |
ScinoPharm Taiwan Management Efficiency
The company has return on total asset (ROA) of 0.0184 % which means that it generated a profit of $0.0184 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0295 %, meaning that it generated $0.0295 on every $100 dollars invested by stockholders. ScinoPharm Taiwan's management efficiency ratios could be used to measure how well ScinoPharm Taiwan manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jianyue Li | WiseChip Semiconductor | N/A | |
| Meng Yang | Apex Biotechnology Corp | N/A | |
| ChingYao Peng | Advanced Ceramic X | N/A | |
| Jian Chen | WiseChip Semiconductor | N/A | |
| Jin Zheng | Giant Manufacturing Co | N/A | |
| ChungYee Pao | Leader Electronics | N/A | |
| ChengTa Tsai | Cathay Financial Holding | N/A | |
| YuMei Lee | Cathay Financial Holding | N/A | |
| MingHo Hsiung | Cathay Financial Holding | N/A | |
| ChingHsin Yen | Giant Manufacturing Co | N/A | |
| Shane Sun | Cathay Financial Holding | N/A | |
| JianHsing Wu | Cathay Financial Holding | N/A | |
| TaChing Hung | Cathay Financial Holding | N/A | |
| ShengChang Chang | Giant Manufacturing Co | N/A | |
| Judie Hsu | Cathay Financial Holding | N/A | |
| Jun Shi | WiseChip Semiconductor | N/A | |
| ShuFen Cheng | Cathay Financial Holding | N/A | |
| LiangChang Chou | Kinko Optical Co | N/A | |
| ChingChi Chen | Kinko Optical Co | N/A | |
| ChiaoLi Pan | Giant Manufacturing Co | N/A | |
| Liling Wang | Cathay Financial Holding | N/A | |
Management Performance
| Return On Equity | 0.0295 | |||
| Return On Asset | 0.0184 |
ScinoPharm Taiwan Leadership Team
Elected by the shareholders, the ScinoPharm Taiwan's board of directors comprises two types of representatives: ScinoPharm Taiwan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ScinoPharm. The board's role is to monitor ScinoPharm Taiwan's management team and ensure that shareholders' interests are well served. ScinoPharm Taiwan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ScinoPharm Taiwan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shun Lin, Director Devel | ||
| ChihHui Lin, Sr Off | ||
| ChihHsien Lo, Chairman of the Board, Chief Strategy Officer | ||
| LiAn Lu, Deputy General Manager-Administrative Management Center | ||
| Jason Chen, Director Admin | ||
| LingHsiao Lien, VicePres Operations | ||
| BS MS, VP Officer | ||
| LiChiao Chemistry, VP Officer |
ScinoPharm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ScinoPharm Taiwan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0295 | |||
| Return On Asset | 0.0184 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 16.28 B | |||
| Shares Outstanding | 790.74 M | |||
| Shares Owned By Insiders | 58.97 % | |||
| Shares Owned By Institutions | 16.86 % | |||
| Price To Earning | 51.64 X | |||
| Price To Book | 1.92 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for ScinoPharm Stock Analysis
When running ScinoPharm Taiwan's price analysis, check to measure ScinoPharm Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScinoPharm Taiwan is operating at the current time. Most of ScinoPharm Taiwan's value examination focuses on studying past and present price action to predict the probability of ScinoPharm Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScinoPharm Taiwan's price. Additionally, you may evaluate how the addition of ScinoPharm Taiwan to your portfolios can decrease your overall portfolio volatility.